| Ytd | -8.72% | |
| 1y | -0.84% |
| Open | 99.36 | Prev Close | 99.02 | Low | 96.88 | High | 99.36 | Mkt Cap | 6.73B |
| Vol | 1.12M | Avg Vol | 711.27K | EPS | -3.12 | P/E | N/A | Forward P/E | -159.50 |
| Beta | 1.97 | Short Ratio | 15.98 | Inst. Own | 114.89% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-03 | 50-d Avg | 107.35 | 200-d Avg | 99.39 | 1yr Est | 138.59 |
RYTM News
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM - Get Free Report) CEO David Meeker sold 50,000 shares of
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM - Get Free Report) traded down 5.3% during mid-day tradin
Rhythm Pharmaceuticals, Inc. (RYTM) Presents at Morgan Stanley 24th Annual Global Healthcare Confere
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
Rhythm Pharmaceuticals (NASDAQ:RYTM) has outperformed the market over the past 5 years by 40.53% on
Rhythm Pharmaceuticals (NASDAQ:RYTM) has outperformed the market over the past 5 years by 40.99% on
Deutsche Bank analyst David Hoang initiates coverage on Rhythm Pharmaceuticals (NASDAQ:RYTM) with
Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company foc